Matthew M. Harmelink, MD

Associate Professor, Chief

Locations

Neurology

Education

BS, Biology, University of Wisconsin-Madison, Madison, WI, 2004
MD, Medical College of Wisconsin, Milwaukee, WI, 2009

Biography

Specialty

Child Neurology

Subspecialties

Pediatric Neuromuscular

Training

Pediatric Residency, University of California Irvine, Orange, CA, 2009–2012

Child Neurology Fellowship, Medical College of Wisconsin, Milwaukee, WI, 2012–2015

Neuromuscular Fellow, University of California-Los Angeles, Los Angeles, CA, 2015–2016

Societies

Wisconsin Medical Society (Member, 2009 Clinical Outcomes Committee member and voting delegate), 2008–2009
American Academy of Pediatrics (Resident Member), 2009–2012
Wisconsin Neurologic Society (Trainee Member), 2012–2016
American Academy of Neurology (Trainee Member), 2012–2016
Child Neurologic Society (Junior Member), 2013–2015
AANEM, 2015–Present
AANEM Podcast Committee member, 2015–Present
AAN Podcast Committee member, 2015–Present

Clinical Interests

Neuromuscular disorders
Muscular Dystrophy and Muscle Diseases
Spinal Muscular Atrophy and Nerve Diseases
Myasthenia Gravis
Critical Illness Neuromyopathy
Electromyography and Nerve Conduction Studies

View Children's Wisconsin Provider Profile

View Faculty Collaboration Database profile

Honors and Awards

Intern of the Year, University of California-Irvine Pediatric Residency, Orange, CA, 2009–2010
Second Year Resident of the Year, University of California-Irvine Pediatric Residency, Orange, CA, 2010–2011
Resident Teaching Award, University of California-Irvine Pediatric Residency, Orange, CA, 2011–2012
Director's Award, University of California-Irvine Pediatric Residency, Orange, CA, 2011–2012
Medical College of Wisconsin's Outstanding Medical Student Teaching Award, Milwaukee, WI, 2012–2013
Fellow Teaching Award, Pediatric Residency Medical College of Wisconsin, Milwaukee, WI, 2014–2015

Clinical Expertise

Caveolin 3
Charcot-Marie-Tooth Disease
Distal Myopathies
Dystrophin
Muscular Atrophy, Spinal
Muscular Dystrophies
Muscular Dystrophies, Limb-Girdle
Muscular Dystrophy, Duchenne
Muscular Dystrophy, Emery-Dreifuss
Muscular Dystrophy, Facioscapulohumeral
Myasthenia Gravis
Myasthenia Gravis, Neonatal

Leadership Positions

Director of Pediatric Neuromuscular Program Associate Program Director, Child Neurology Residency

Research Interests

Treatment of Spinal Neuromuscular Atrophy, Diagnostics in Pediatric Neuromuscular Disease, Complex Febrile Seizures

Assessment of cerebral spinal fluid biomarkers and microRNA-mediated disease mechanisms in spinal muscular atrophy patient samples.

(Welby E, Rehborg RJ, Harmelink M, Ebert AD.) Hum Mol Genet. 2022 06 04;31(11):1830-1843 PMID: 34919695 SCOPUS ID: 2-s2.0-85123796645 12/18/2021
Uncommon Causes of Rhabdomyolysis.

(Harmelink M.) Crit Care Clin. 2022 Apr;38(2):271-285 PMID: 35369947 04/05/2022
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

(McDonald CM, Marb?!n E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marb?!n L, HOPE-2 Study Group.) Lancet. 2022 03 12;399(10329):1049-1058 PMID: 35279258 03/14/2022
Newborn screening for spinal muscular atrophy: The Wisconsin first year experience.

(Baker MW, Mochal ST, Dawe SJ, Wiberley-Bradford AE, Cogley MF, Zeitler BR, Piro ZD, Harmelink MM, Kwon JM.) Neuromuscul Disord. 2022 02;32(2):135-141 PMID: 35120759 02/06/2022
Pediatrician Exposure to Neuromuscular Patients.

(Harmelink M, Yale E.) WMJ. 2021 Apr;120(1):66-68 PMID: 33974769 05/12/2021
Acute flaccid myelitis: cause, diagnosis, and management.

(Murphy OC, Messacar K, Benson L, Bove R, Carpenter JL, Crawford T, Dean J, DeBiasi R, Desai J, Elrick MJ, Farias-Moeller R, Gombolay GY, Greenberg B, Harmelink M, Hong S, Hopkins SE, Oleszek J, Otten C, Sadowsky CL, Schreiner TL, Thakur KT, Van Haren K, Carballo CM, Chong PF, Fall A, Gowda VK, Helfferich J, Kira R, Lim M, Lopez EL, Wells EM, Yeh EA, Pardo CA, AFM working group.) Lancet. 2021 01 23;397(10271):334-346 PMID: 33357469 PMCID: PMC7909727 12/29/2020
Anti-Ku antibody-positive systemic sclerosis-polymyositis overlap syndrome in an adolescent.

(Loo RJ, Nocton JJ, Harmelink MM, Chiu YE.) Pediatr Dermatol. 2020 Sep;37(5):960-961 PMID: 32519400 SCOPUS ID: 2-s2.0-85086159645 06/11/2020
Differentiating Congenital Myopathy from Congenital Muscular Dystrophy.

(Harmelink M.) Clin Perinatol. 2020 03;47(1):197-209 PMID: 32000926 02/01/2020
Case report: Femoral neuropathy with conduction block.

(Harmelink M, Pyzik E, Barkhaus PE.) J Neurol Sci. 2019 Jun 15;401:17-18 PMID: 31004831 SCOPUS ID: 2-s2.0-85064246473 04/21/2019
Severe Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy.

(Helbling DC, Mendoza D, McCarrier J, Vanden Avond MA, Harmelink MM, Barkhaus PE, Basel D, Lawlor MW.) J Neuropathol Exp Neurol. 2019 03 01;78(3):283-287 PMID: 30715496 PMCID: PMC6380315 SCOPUS ID: 2-s2.0-85063882669 02/05/2019
Siblings With Mutations in TRAPPC11 Presenting With Limb-Girdle Muscular Dystrophy 2S.

(Fee DB, Harmelink M, Monrad P, Pyzik E.) J Clin Neuromuscul Dis. 2017 Sep;19(1):27-30 PMID: 28827486 SCOPUS ID: 2-s2.0-85028630388 08/23/2017
Complex febrile seizures-A systematic review.

(Whelan H, Harmelink M, Chou E, Sallowm D, Khan N, Patil R, Sannagowdara K, Kim JH, Chen WL, Khalil S, Bajic I, Keval A, Greydanus D.) Dis Mon. 2017 Jan;63(1):5-23 PMID: 28089358 SCOPUS ID: 2-s2.0-85009804801 01/17/2017

Neurology